期刊文献+

血前列腺特异抗原的相关影响因素及其在前列腺癌筛查中的意义 被引量:3

The Factors Relating to Prostate Specific Antigen and Prostate Cancer Screening
下载PDF
导出
摘要 目的:探讨血前列腺特异抗原(PSA)的相关影响因素及其在前列腺癌筛查中的意义。方法:随机选取1572名40岁以上健康体检的男性,进行血PSA检查及相关问卷的调查。结果:血PSA水平与尿不净、中断排尿、排尿费力、尿频、尿急、夜尿都存在正相关关系,但相关性不高;年龄与血PSA水平有明确的相关性;血PSA水平与吸烟、豆制品、西红柿、饮食类型有相关性;是否患有糖尿病、高血压、肿瘤、睾丸疾病与血PSA水平无明显相关性;当血PSA〉4.0.g/ml时,人们接受无创性影像学检查如MRI的比例较高,约95.7%;而接受有创性检查如前列腺穿刺活检的比例较低,约9.7%;在1572名行血PSA检查的人群中前列腺癌检出率约0.19%。结论:对于血PSA检测结果应进行综合分析,且依据血PSA检查结果指导病人何时行前列腺MRI检查及(或)前列腺穿刺活检,以避免过度医疗同时有效减少漏诊率。 OBJECTIVE: To discuss the related influence factors of blood PSA and its signigicance in peostate cancer screening. METHODS: 1572 healthy men individuals ( 〉40 years old) were randomly selected. Among them blood PSA tests and questionnaire survey were made. RESULTS: Blood PSA levels were positively related to interrupt micturition, micturition arduous, urinary frequency, urgency and nocturia, but the correlation was not high. Age was clearly related to blood PSA level. Blood PSA levels were related to smoking, bean products, tomatwes and type of diet. Diabetes, hypertension, cancer and testicular diseases were not obviously related to blood PSA level. At blood PSA 〉 4. 0ng/ml, people who accepted noninvasive imaging examination such as MRI was high (95.7%) and who accepted invasive examination such as prostate biopsy was low (9. 7% ). Prostate cancer detected was about 0. 19% among 1572 people who tested blood PSA. CONCLUSION: Comprehensive analysis should be done for blood PSA test results. And the patients should be told when MRI of the prostate and prostate biopsy should be done on the basis of blood PSA test results.
出处 《国际老年医学杂志》 2017年第2期73-76,共4页 International Journal of Geriatrics
关键词 前列腺癌 前列腺特异抗原 筛查 影响因素 Prostate cancer Prostate specific antigen Screening Influencing factors
  • 相关文献

参考文献2

二级参考文献19

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献924

同被引文献28

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部